TCL Archive DCPC Board Approves $40 Million In New Concepts, Including Three In Breast Cancer, One In Melanoma October 12, 1984
TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980
TCL Archive FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote December 11, 1987
TCL Archive Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study March 6, 1992
